Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Detecting novel splice variants contributing to breast cancer using next-generation mRNA sequencing.

EF 2009-10

Résumé
A recent technological advance, known as next-generation sequencing, now allows us to read the DNA sequence of entire genomes. This approach is already invaluable in detecting mutations responsible for genetic disorders. A related approach, next-generation mRNA sequencing (RNA-Seq), simultaneously monitors the level of expression and provides exact information on the structural variants of every gene in the genome. This is important because more than 90% of human genes are expressed in more than one form, or splice variant, whose functions may be quite different from each other. Aberrant splicing is known to occur in breast cancer yet the role of splice variants in tumor development is poorly understood. This project will use RNA-Seq to discover novel splice variants in breast cancer. We will analyze breast cancer cell lines, matched breast tumor and healthy tissue samples, and matched primary and metastatic tumors from several patients. RNA-Seq generates about 20 billion bits of data per sample. Decoding this information and interpreting its biological relevance involves developing new computational algorithms. Computer programs will be created to identify the anomalies between splice variants in cancer and healthy cells. These results will help resolve our group's hypothesis that irregular splicing contributes to breast cancer progression. Detecting abnormal splice variants will provide important insights into the molecular mechanism of breast cancer. Moreover, diagnostic indicators can be improved: instead of screening a patient's DNA for the main form of a breast cancer gene, tests would be more comprehensive by screening for all variants of this gene. Furthermore, if a variant has a new function which plays a role in cancer development, new drugs can be created to target this variant. Therefore, the discovery of splice variants has significant implications for the improved detection and treatment of the 1 in 9 Canadian women affected by breast cancer
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
200314
Name
Lalonde Emilie R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Detecting novel splice variants contributing to breast cancer using next-generation mRNA sequencing.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Breast Cancer; Computational Genomics; Gene Expression; Genetics; Genomics; Next-Generation Sequencing; Splice Variants; Splicing Regulation; Transcriptomics
Abstract
A recent technological advance, known as next-generation sequencing, now allows us to read the DNA sequence of entire genomes. This approach is already invaluable in detecting mutations responsible for genetic disorders. A related approach, next-generation mRNA sequencing (RNA-Seq), simultaneously monitors the level of expression and provides exact information on the structural variants of every gene in the genome. This is important because more than 90% of human genes are expressed in more than one form, or splice variant, whose functions may be quite different from each other. Aberrant splicing is known to occur in breast cancer yet the role of splice variants in tumor development is poorly understood. This project will use RNA-Seq to discover novel splice variants in breast cancer. We will analyze breast cancer cell lines, matched breast tumor and healthy tissue samples, and matched primary and metastatic tumors from several patients. RNA-Seq generates about 20 billion bits of data per sample. Decoding this information and interpreting its biological relevance involves developing new computational algorithms. Computer programs will be created to identify the anomalies between splice variants in cancer and healthy cells. These results will help resolve our group's hypothesis that irregular splicing contributes to breast cancer progression. Detecting abnormal splice variants will provide important insights into the molecular mechanism of breast cancer. Moreover, diagnostic indicators can be improved: instead of screening a patient's DNA for the main form of a breast cancer gene, tests would be more comprehensive by screening for all variants of this gene. Furthermore, if a variant has a new function which plays a role in cancer development, new drugs can be created to target this variant. Therefore, the discovery of splice variants has significant implications for the improved detection and treatment of the 1 in 9 Canadian women affected by breast cancer
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lalonde, Emilie R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~